Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock enjoyed a major increase of 10.2% on 8/12/24. The shares closed at $11.25. However, below average trading volume at 78% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 16.0% during the last week.
Current PriceTarget Research Rating
RIGL is expected to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment